focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNcc Regulatory News (NCC)

Share Price Information for Ncc (NCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 135.60
Bid: 136.00
Ask: 136.40
Change: -1.00 (-0.73%)
Spread: 0.40 (0.294%)
Open: 136.00
High: 137.60
Low: 135.60
Prev. Close: 136.60
NCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - NCC Group PLC

26 Mar 2015 17:38

MONTANARO UK SMALLER COMPANIES INVESTMENT TRUST PLC - Form 8.3 - NCC Group PLC

MONTANARO UK SMALLER COMPANIES INVESTMENT TRUST PLC - Form 8.3 - NCC Group PLC

PR Newswire

London, March 26

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Montanaro UK Smaller Companies Investment Trust PLC (b) Owner or controller of interests and shortpositions disclosed, if different from 1(a): The naming of nominee or vehicle companies isinsufficient. For a trust, the trustee(s),settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to NCC Group PLCwhose relevant securities this form relates: Use a separate form for each offeror/offeree (d) If an exempt fund manager connected withan offeror/offeree, state this and specifyidentity of offeror/offeree: (e) Date position held/dealing undertaken: 25/03/2015 For an opening position disclosure, state thelatest practicable date prior to thedisclosure (f) In addition to the company in 1(c) above, NOis the discloser making disclosures in respectof any other party to the offer? If it is a cash offer or possible cash offer,state "N/A" 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than oneclass of relevant securities of the offeror or offeree named in 1(c), copytable 2(a) or (b) (as appropriate) for each additional class of relevantsecurity. (a) Interests and short positions in the relevant securities of the offeror orofferee to which the disclosure relates following the dealing (if any) Class of relevant security: 1p ordinary Interests Short positions Number % Number % (1) Relevant securities owned 3,112,500 1.49and/or controlled: (2) Cash-settled derivatives: (3) Stock-settled derivatives(including options) andagreements to purchase/sell: TOTAL: 3,112,500 1.49 All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including tradedoptions), or agreements to purchase or sell relevant securities, should begiven on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors' and otheremployee options) Class of relevant security inrelation to which subscription rightexists: Details, including nature of therights concerned and relevantpercentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities ofthe offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (asappropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant Purchase/sale Number of Price per unit security securities (b) Cash-settled derivative transactions Class of Product Nature of dealing Number of Price per relevant description reference unit security e.g. opening/closing a securities e.g. CFD long/short position, increasing/reducing a long/short position (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of Product Writing, Number of Exercise Type Expiry Optionrelevant description purchasing, securities price date moneysecurity e.g. call selling, to which per unit e.g. paid/ option varying option American, received etc. relates European per unit etc. (ii) Exercise Class of Product Exercising/ Number of Exercise price relevant description exercised securities per unit security against e.g. call option (d) Other dealings (including subscribing for new securities) Class of relevant Nature of dealing Details Price per unit security (if applicable) e.g. subscription, conversion 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement orunderstanding, formal or informal, relating to relevant securities which maybe an inducement to deal or refrain from dealing entered into by the personmaking the disclosure and any party to the offer or any person acting inconcert with a party to the offer: Irrevocable commitments and letters of intent should not be included. Ifthere are no such agreements, arrangements or understandings, state "none" none (b) Agreements, arrangements or understandings relating to options orderivatives Details of any agreement, arrangement or understanding, formal or informal,between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevantsecurities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" none (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 26.03.2015 Contact name: James Rice Telephone number: 01392 477583 Public disclosures under Rule 8 of the Code must be made to a RegulatoryInformation Service and must also be emailed to the Takeover Panel atmonitoring@disclosure.org.uk . The Panel's Market Surveillance Unit isavailable for consultation in relation to the Code's disclosure requirements on+44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Date   Source Headline
2nd May 20247:00 amRNSCapital Markets Event for CSMS
1st May 20248:16 amRNSDirector Declaration
24th Apr 20247:00 amRNSAppointment of Joint Broker
18th Apr 20241:12 pmRNSDirector/PDMR Shareholding
16th Apr 202411:29 amRNSDirector/PDMR Shareholding
15th Apr 20244:04 pmRNSHolding(s) in Company
12th Apr 20241:05 pmRNSHolding(s) in Company
9th Apr 20247:00 amRNSCapital Markets Event for Escode
21st Mar 20244:35 pmRNSDirector Declaration
19th Mar 20241:31 pmRNSDirector/PDMR Shareholding
19th Mar 20249:44 amRNSHolding(s) in Company
12th Mar 20245:35 pmRNSHolding(s) in Company
12th Mar 202412:03 pmRNSHolding(s) in Company
20th Feb 202412:36 pmRNSDirector/PDMR Shareholding
31st Jan 20245:30 pmRNSBlock Listing Six Monthly Return
31st Jan 20243:56 pmRNSTR-1: Holding(s) in Company
29th Jan 20245:45 pmRNSChange of Auditor
25th Jan 20247:00 amRNSUnaudited interim results - period ended 30/11/23
18th Jan 20242:58 pmRNSDirector/PDMR Shareholding
21st Dec 20238:02 amRNSStrategic disposal of DetACT
19th Dec 20234:28 pmRNSDirector/PDMR Shareholding
13th Dec 20231:26 pmRNSDirector/PDMR Shareholding
1st Dec 20234:06 pmRNSDirector/PDMR Shareholding
30th Nov 20231:48 pmRNSResults of the 2023 Annual General Meeting
30th Nov 20237:00 amRNSAGM Trading Statement
21st Nov 20235:09 pmRNSBlock Listing Application
21st Nov 20233:51 pmRNSDirector/PDMR Shareholding
31st Oct 20232:13 pmRNSTotal Voting Rights
31st Oct 202311:44 amRNSDirector/PDMR Shareholding
27th Oct 202312:37 pmRNSDirector/PDMR Shareholder Dealing
24th Oct 20235:10 pmRNSHolding(s) in Company
18th Oct 20232:15 pmRNSDirector/PDMR Shareholding
18th Oct 20232:06 pmRNSDirector/PDMR Shareholding
11th Oct 202312:31 pmRNSHolding(s) in Company
11th Oct 202312:21 pmRNSDirector/PDMR Shareholding
10th Oct 20231:07 pmRNSNotice of Annual General Meeting - 2023
10th Oct 202312:52 pmRNSDirector/PDMR Shareholding
5th Oct 202312:58 pmRNSDirector/PDMR Shareholding
4th Oct 20233:26 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:28 pmRNSHolding(s) in Company
28th Sep 20235:07 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSPreliminary unaudited FY 2023 Results
20th Sep 202310:44 amRNSHolding(s) in Company
19th Sep 20233:24 pmRNSDirector/PDMR Shareholding
19th Sep 202311:35 amRNSHolding(s) in Company
19th Sep 202311:31 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSChange to date of Prelim results & trading update
23rd Aug 20232:02 pmRNSHolding(s) in Company
18th Aug 20231:27 pmRNSDirector/PDMR Shareholding
31st Jul 20233:09 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.